Acutaas Chemicals Ltd announces a leadership change

The proposed fixed and variable remuneration amounts, and therefore the fixed-to-variable ratio, cannot be determined from the cited disclosure. The regulatory notice only records shareholder approval for Mr. Ram Mohan Lokhande’s re-appointment as Whole Time Director for five years from 8 February 2027 to 7 February 2032, along with approval for payment of remuneration; it does not reproduce the remuneration breakup or the comparison with his previous term. ^[1]

Accordingly:

• Proposed remuneration structure: fixed component, variable component, and any limits or performance conditions are not stated in the cited notice.
• Comparison with the previous five-year term: no fixed-to-variable ratios for either the proposed term or the previous term are provided, so no change in the ratio can be calculated.
• The accompanying director-details table also covers the appointment term and profile, but does not provide remuneration figures. ^[2]

Cumulative tenure: The filing confirms that Mrs. Anita Bandyopadhyay is being re-appointed for a second five-year term, from 8 February 2027 to 7 February 2032. ^[1] It does not state the duration or completion date of her first term, so her exact cumulative tenure cannot be established from this disclosure. If her first term was also a full five years, the implied cumulative tenure would be 10 years, but that is a conditional inference rather than an expressly reported figure.

What supports the continued association: The disclosed profile highlights her:

• Doctorate in Applied Psychology and Executive MBA;
• expertise in strategic HR management, leadership development, talent and performance management;
• experience in organisational design and corporate succession planning. ^[2]

The disclosure does not identify any specific committee chairmanships or memberships as a reason for re-appointment. It also does not expressly link her expertise to a particular SEBI LODR independence test. Separately, it records that she is not related to other directors or KMP and is not debarred by SEBI or another authority. ^[3]

Assessment: The explanatory material presents her HR and organisational expertise as the main rationale for continuity, but provides no committee-based justification and does not itself establish compliance with every SEBI LODR independence criterion. The filing confirms selected eligibility-related declarations; it does not provide the complete factual basis needed to independently verify her entire cumulative tenure or all statutory independence conditions.

A quantitative comparison cannot be made from the cited disclosures. Acutaas’ filing confirms shareholder approval for Ram Mohan Lokhande’s re-appointment as Whole Time Director for five years from 8 February 2027 to 7 February 2032, including approval for payment of remuneration, but it does not state the proposed amount, fixed pay, variable pay, perquisites, or total remuneration ^[1].

Accordingly, there is no supportable basis to calculate either:

• the proposed Whole Time Director remuneration at Acutaas; or
• the median executive compensation across the named peers.

The comparison also requires a consistent definition—such as total annual remuneration of the CEO/Whole Time Director or total remuneration of all key managerial personnel. Median employee remuneration, which is a different statutory disclosure, should not be used as a proxy for executive compensation.

Analytical implication: the available disclosure establishes approval and tenure, not the economic cost of the appointment. A premium-or-discount assessment versus peers would therefore be speculative until Acutaas’ annual-report remuneration table or explanatory statement and comparable peer remuneration disclosures are available.